Academic literature on the topic 'Hepatitis D virus (HDV)'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Hepatitis D virus (HDV).'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Hepatitis D virus (HDV)"

1

Mhlanga, Adequate, Rami Zakh, Alexander Churkin, et al. "Modeling the Interplay between HDV and HBV in Chronic HDV/HBV Patients." Mathematics 10, no. 20 (2022): 3917. http://dx.doi.org/10.3390/math10203917.

Full text
Abstract:
Hepatitis D virus is an infectious subviral agent that can only propagate in people infected with hepatitis B virus. In this study, we modified and further developed a recent model for early hepatitis D virus and hepatitis B virus kinetics to better reproduce hepatitis D virus and hepatitis B virus kinetics measured in infected patients during anti-hepatitis D virus treatment. The analytical solutions were provided to highlight the new features of the modified model. The improved model offered significantly better prospects for modeling hepatitis D virus and hepatitis B virus interactions.
APA, Harvard, Vancouver, ISO, and other styles
2

Crobu, Maria Grazia, Paolo Ravanini, Clotilde Impaloni, et al. "Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection." Viruses 16, no. 6 (2024): 992. http://dx.doi.org/10.3390/v16060992.

Full text
Abstract:
Previous studies reported that the hepatitis C virus (HCV) could help disseminate the hepatitis D virus (HDV) in vivo through the unrelated hepatitis B virus (HBV), but with essentially inconclusive results. To try to shed light on this still-debated topic, 146 anti-HCV-positive subjects (of whom 91 HCV/HIV co-infected, and 43 with prior HCV eradication) were screened for anti-HDV antibodies (anti-HD), after careful selection for negativity to any serologic or virologic marker of current or past HBV infection. One single HCV/HIV co-infected patient (0.7%) tested highly positive for anti-HD, bu
APA, Harvard, Vancouver, ISO, and other styles
3

Srinivas, G., D.V. Ramanjaneyulu, E. Muralinath, et al. "Hepatitis D Virus Diagnosis by Isolation, Characterization, Treated with Antibodies and Evaluating the Patients." Journal of Surgical Nursing and Post Operative Nursing Care 3, no. 2 (2025): 9–17. https://doi.org/10.5281/zenodo.15523922.

Full text
Abstract:
<em>Hepatitis B virus (HBV) is necessary for the reproduction and dissemination of the hepatitis D virus (HDV), a distinct disease. Since HDV employs the HBV surface antigen as its envelope protein, it must co-infect or superinfect with HBV in order to produce illness. Compared to HBV alone, an HDV infection can clinically cause more severe liver damage. In patients with acute HBV-HDV coinfection, the sequential spread of HBV and HDV may be reflected by a biphasic course and two different peaks in blood alanine aminotransferase. Cirrhosis and liver failure may progress more quickly in cases of
APA, Harvard, Vancouver, ISO, and other styles
4

Chu, Chia-Ming, Chau-Ting Yeh, and Yun-Fan Liaw. "Low-Level Viremia and Intracellular Expression of Hepatitis B Surface Antigen (HBsAg) in HBsAg Carriers with Concurrent Hepatitis C Virus Infection." Journal of Clinical Microbiology 36, no. 7 (1998): 2084–86. http://dx.doi.org/10.1128/jcm.36.7.2084-2086.1998.

Full text
Abstract:
Assays of hepatitis B virus (HBV) replication and antigen expression in HBV surface antigen (HBsAg) carriers with concurrent hepatitis C or D virus (HCV or HDV) infection revealed that HCV and HDV can suppress HBV replication but that HCV also substantially suppresses HBV surface protein expression. HBsAg carriers with concurrent HCV infection thus have low-level viremia and intracellular HBsAg.
APA, Harvard, Vancouver, ISO, and other styles
5

Schinas, Georgios, Nikolina Antonopoulou, Sofia Vamvakopoulou, et al. "Prevalence of Hepatitis D in People Living with HIV: A National Cross-Sectional Pilot Study." Viruses 16, no. 7 (2024): 1044. http://dx.doi.org/10.3390/v16071044.

Full text
Abstract:
This study assesses the prevalence of hepatitis D virus (HDV) in people living with HIV (PLWHIV) in Greece. Given the compounding effects of HDV and hepatitis B (HBV) on liver disease progression, as well as the emergence of new therapeutic options such as bulevirtide, understanding regional disparities and the epidemiological impact of such co-infections is vital. A cross-sectional analysis was conducted utilizing 696 serum samples from PLWHIV attending five major university hospitals. The methodology included HDV antibody detection by ELISA and HDV RNA confirmation. Of the 30 HBsAg-positive
APA, Harvard, Vancouver, ISO, and other styles
6

Farci, Patrizia, Grazia Anna Niro, Fausto Zamboni, and Giacomo Diaz. "Hepatitis D Virus and Hepatocellular Carcinoma." Viruses 13, no. 5 (2021): 830. http://dx.doi.org/10.3390/v13050830.

Full text
Abstract:
Hepatitis D virus (HDV) is a small, defective RNA virus that depends on hepatitis B virus (HBV) for virion assembly and transmission. It replicates within the nucleus of hepatocytes and interacts with several cellular proteins. Chronic hepatitis D is a severe and progressive disease, leading to cirrhosis in up to 80% of cases. A high proportion of patients die of liver decompensation or hepatocellular carcinoma (HCC), but the lack of large prospective studies has made it difficult to precisely define the rate of these long-term complications. In particular, the question of whether HDV is an on
APA, Harvard, Vancouver, ISO, and other styles
7

Udosen, Joseph E., Euphoria C. Akwiwu, Dennis A. Abunimye, Utibe-Abasi Felix, David U. Akpotuzor, and Josephine O. Akpotuzor. "Prevalence of Hepatitis B, C and D Infections in Preoperative Patients at a Tertiary Hospital in Southern Nigeria." Sokoto Journal of Medical Laboratory Science 8, no. 1 (2023): 40–43. http://dx.doi.org/10.4314/sokjmls.v8i1.5.

Full text
Abstract:
Patients going for surgical operations are required to be screened for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among other transmissible infections. This is necessary for better assessment of the patient's condition alongside the need for extra precautions during surgery. Hepatitis D virus (HDV) infection is not commonly reported but occurs in association with commonly reported but occurs in association with that of hepatitis B virus. The epidemiology of this co-infection is worth investigating, as it constitutes a more aggressive form of hepatitis Following due ethical
APA, Harvard, Vancouver, ISO, and other styles
8

Tserashkou, D. V., V. M. Mitsura, E. V. Voropaev, and O. V. Osipkina. "VIRAL COINFECTIONS IN PATIENTS WITH CHRONIC HEPATITIS B: THEIR PREVALENCE AND CLINICAL SIGNIFICANCE." Hepatology and Gastroenterology 4, no. 2 (2020): 171–76. http://dx.doi.org/10.25298/2616-5546-2020-4-2-171-176.

Full text
Abstract:
Background. Hepatitis B virus (HBV) infection remains a global public health problem. Objective – to analyze the prevalence of viral coinfections with human immunodefciency virus (HIV), hepatitis C virus (HCV), hepatitis delta virus (HDV), TT-viruses and SENV in patients with chronic hepatitis B (CHB) and to assess their influence on liver disease severity. Material and methods. The observational cross-sectional study included 287 patients with chronic hepatitis B virus (HBV) – those with monoinfection and coinfected with HIV, HCV, HDV. Routine hematological and biochemical tests were performed
APA, Harvard, Vancouver, ISO, and other styles
9

Takahashi, Masaharu, Tsutomu Nishizawa, Yuhko Gotanda, et al. "High Prevalence of Antibodies to Hepatitis A and E Viruses and Viremia of Hepatitis B, C, and D Viruses among Apparently Healthy Populations in Mongolia." Clinical Diagnostic Laboratory Immunology 11, no. 2 (2004): 392–98. http://dx.doi.org/10.1128/cdli.11.2.392-398.2004.

Full text
Abstract:
ABSTRACT The prevalence of infection with hepatitis A virus (HAV), HBV, HCV, HDV, and HEV was evaluated in 249 apparently healthy individuals, including 122 inhabitants in Ulaanbaatar, the capital city of Mongolia, and 127 age- and sex-matched members of nomadic tribes who lived around the capital city. Overall, hepatitis B surface antigen (HBsAg) was detected in 24 subjects (10%), of whom 22 (92%) had detectable HBV DNA. Surprisingly, HDV RNA was detectable in 20 (83%) of the 24 HBsAg-positive subjects. HCV-associated antibodies were detected in 41 (16%) and HCV RNA was detected in 36 (14%) s
APA, Harvard, Vancouver, ISO, and other styles
10

Makiala-Mandanda, Sheila, Frédéric Le Gal, Nadine Ngwaka-Matsung, et al. "High Prevalence and Diversity of Hepatitis Viruses in Suspected Cases of Yellow Fever in the Democratic Republic of Congo." Journal of Clinical Microbiology 55, no. 5 (2017): 1299–312. http://dx.doi.org/10.1128/jcm.01847-16.

Full text
Abstract:
ABSTRACTThe majority of patients with acute febrile jaundice (&gt;95%) identified through a yellow fever surveillance program in the Democratic Republic of Congo (DRC) test negative for antibodies against yellow fever virus. However, no etiological investigation has ever been carried out on these patients. Here, we tested for hepatitis A (HAV), hepatitis B (HBV), hepatitis C (HCV), hepatitis D (HDV), and hepatitis E (HEV) viruses, all of which can cause acute febrile jaundice, in patients included in the yellow fever surveillance program in the DRC. On a total of 498 serum samples collected fr
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Hepatitis D virus (HDV)"

1

Alfaiate, Dulce. "Study of the interplay between hepatitis B and hepatitis delta viruses and evaluation of investigational anti-HDV immuno-modulators in superinfection cell culture models." Thesis, Lyon 1, 2015. http://www.theses.fr/2015LYO10123/document.

Full text
Abstract:
La surinfection par HDV/ HBV est la forme la plus grave d'hépatite virale chronique et affecte entre 15-20 millions de patients au niveau mondial. HDV n'est pas susceptible aux traitements anti-HBV et le taux de réponse à l'IFNα est &lt;25%. Malgré une progression plus rapide de la maladie hépatique, la majorité des patients présente une suppression de la réplication du HBV. Les détails des interactions entre HDV, HBV et le système immunitaire inné des cellules infectées restent inconnus. Les objectifs de ces travaux de thèse ont été: i) l'étude de l'infection par HDV et son interaction avec l
APA, Harvard, Vancouver, ISO, and other styles
2

Shirvani-Dastgerdi, Elham [Verfasser], Frank [Akademischer Betreuer] Tacke, and Jürgen [Akademischer Betreuer] Bernhagen. "Hepatitis B virus (HBV) and delta virus (HDV) interactions : effects of HDV replication on drug resistance, immune escape and HBeAg-negative mutants of HBV / Elham Shirvani-Dastgerdi ; Frank Tacke, Jürgen Bernhagen." Aachen : Universitätsbibliothek der RWTH Aachen, 2016. http://d-nb.info/1127051369/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Abeywickrama, Samarakoon Natali. "Small hepatitis Delta antigen mimics a histone H3 epitope to facilitate the remodeling of the Hepatitis D virus (HDV) viral ribonucleoprotein." Thesis, Lyon, 2016. http://www.theses.fr/2016LYSE1193.

Full text
Abstract:
Le virus de l'hépatite Delta (HDV) est un agent infectieux transmissible satellite du virus de l'hépatite B (HBV), induisant des maladies du foie plus sévères que la mono–infection par le HBV. Aucun traitement totalement efficace n'est disponible contre l'HDV et les 15 millions de personnes infectées par le HDV dans le monde sont exposées a un risque élevé de cirrhose et de carcinome hépatocellulaire. HDV est un virus unique qui ne code pas pour une polymérase virale contrairement aux autres virus a ARN. La réplication de l'ARN HDV s'effectue par un double mécanisme de cercle roulant générant
APA, Harvard, Vancouver, ISO, and other styles
4

El, Chaar Mira Hisham. "Production and characterisation of mutant recombinant hepatitis B virus (HBV) surface proteins identified in genotype D occult HBV infections." Thesis, University of Cambridge, 2011. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.609619.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wilhelm, Frank [Verfasser]. "Prävalenzen und Risikofaktoren für Hepatitis-B- und -C-Virus-Infektionen bei HAART-naiven HIV-Patienten / Frank Wilhelm." Köln : Deutsche Zentralbibliothek für Medizin, 2013. http://d-nb.info/1036140105/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Lange, Milena [Verfasser], Michael [Akademischer Betreuer] Roggendorf, Astrid [Akademischer Betreuer] Westendorf, and Daniel [Akademischer Betreuer] Hoffmann. "A new vaccine strategy for HCV : presentation of Hepatitis C Virus hypervariable region 1 on HBV capsid-like particles / Milena Lange. Gutachter: Astrid Westendorf ; Daniel Hoffmann. Betreuer: Michael Roggendorf." Duisburg, 2012. http://d-nb.info/1026012228/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Körner, Christian [Verfasser]. "Untersuchungen zum Einfluss der Hepatitis C-Virus-Koinfektion auf die Immunrekonstitution bei HIV-positiven Patienten unter einer hochaktiven antiretroviralen Therapie / Christian Körner. Mathematisch-Naturwissenschaftliche Fakultät." Bonn : Universitäts- und Landesbibliothek Bonn, 2011. http://d-nb.info/1018326928/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Gong, Bo. "Raman spectroscopic studies of the hepatitis delta virus (HDV) ribozyme." Case Western Reserve University School of Graduate Studies / OhioLINK, 2009. http://rave.ohiolink.edu/etdc/view?acc_num=case1228319219.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Gong, Bo. "Raman spectroscopic studies of the hepatitis delta virus (HDV) ribozyme." Cleveland, Ohio : Case Western Reserve University, 2008. http://rave.ohiolink.edu/etdc/view?acc%5Fnum=case1228319219.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Bock, Julia Friederike [Verfasser], Thomas [Akademischer Betreuer] Berg, Bömmel Florian [Akademischer Betreuer] van, Claus-Thomas [Gutachter] Bock, and Uwe [Gutachter] Liebert. "Untersuchung der Dynamik von Resistenzvarianten des Hepatitis-B-Virus unter Drittlinientherapie mit Tenofovir mittels Tiefenpyrosequenzierung bei Patienten mit chronischer Hepatitis-B-Virusinfektion mit Schwerpunkt auf den Adefovir-Resistenzvarianten und Verlauf der HBV-Quasispezies / Julia Friederike Bock ; Gutachter: Claus-Thomas Bock, Uwe Liebert ; Thomas Berg, Florian van Bömmel." Leipzig : Universitätsbibliothek Leipzig, 2017. http://d-nb.info/1240846290/34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Hepatitis D virus (HDV)"

1

Lindh, Gudrun. Chronic hepatitis B: Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum. Distributed by the Almqvist & Wiksell Periodical Co., 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

institutet, Karolinska, ed. Chronic hepatitis B: Impact of hepatitis D virus superinfection and the hepatitis B e-system on histological outcome, and correlation of the hepatitis B e-system to HBV-DNA in serum. Distributed by Almqvist & Wiksell Periodical Co., 1986.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1953-, Hamatake Robert Kiyoshi, and Lau Johnson Y. N, eds. Hepatitis B and D protocols. Humana Press, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gail, Dinter-Gottlieb, ed. The unique hepatitis delta virus. R.G. Landes Co., 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Mario, Rizzetto, Gerin John L, and Purcell Robert H, eds. The Hepatitis delta virus and its infection: Proceedings of an International Symposium on Hepatitis Delta Virus, held in Saint Vincent, Italy, June 19 to 20, 1986. Liss, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

L, Gerin John, Purcell Robert H, and Rizzetto Mario, eds. The hepatitis delta virus: Proceedings of the Third International Symposium on Hepatitis Delta Virus, held in Washington, D.C., October 26-28, 1989. Wiley-Liss, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wilson, Deanna. Hepatitis. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199976805.003.0035.

Full text
Abstract:
Hepatitis A (HAV) and E (HEV) viruses are spread via the fecal-oral route. Hepatitis B virus (HBV) exposure is via occupational or recreational activities. Hepatitis D virus (HDV; also spread parentally) can only coinfect or superinfect those with chronic HBV. Hepatitis C (HCV) transmission is predominantly parenteral; the highest risk group is injection drug users. Prodromal-period patients with acute hepatitis present with vague constitutional symptoms when serum transaminases peak, with elevated serum bilirubin and varying levels of hepatic protein synthesis impairment; during the icteric p
APA, Harvard, Vancouver, ISO, and other styles
8

Keshav, Satish, and Palak Trivedi. Viral hepatitis. Edited by Patrick Davey and David Sprigings. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199568741.003.0212.

Full text
Abstract:
Hepatitis means ‘inflammation of the liver’ and is manifest with symptoms that include malaise, anorexia, fever, flu-like symptoms, and pain in the right upper quadrant of the abdomen, with the pain being caused by swelling of the liver and its capsule. Elevations in circulating hepatic enzymes, particularly aspartate transaminase and alanine transaminase, are common, with jaundice occurring some time after the onset of other symptoms and signs. There are five viruses that primarily cause viral hepatitis: hepatitis A, B, C, D, and E viruses, abbreviated HAV, HBV, HCV, HDV, and HEV, respectivel
APA, Harvard, Vancouver, ISO, and other styles
9

Handa, Hiroshi, and Yuki Yamaguchi. Hepatitis Delta Virus. Springer London, Limited, 2006.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Handa, Hiroshi, and Yuki Yamaguchi. Hepatitis Delta Virus. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Hepatitis D virus (HDV)"

1

Ehling, A., B. Gierten, and T. Arndt. "Hepatitis D-Virus (HDV)." In Lexikon der Medizinischen Laboratoriumsdiagnostik. Springer Berlin Heidelberg, 2018. http://dx.doi.org/10.1007/978-3-662-49054-9_1430-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Ehling, A., B. Gierten, and T. Arndt. "Hepatitis D-Virus (HDV)." In Springer Reference Medizin. Springer Berlin Heidelberg, 2019. http://dx.doi.org/10.1007/978-3-662-48986-4_1430.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Meisel, Helga, Stefanie Märschenz, and Detlev H. Krüger. "Hepatitis D Virus (HDV)." In Lexikon der Infektionskrankheiten des Menschen. Springer Berlin Heidelberg, 2009. http://dx.doi.org/10.1007/978-3-540-39026-8_452.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Young, Hugh, and Marie Ogilvie. "Hepatitis D virus (HDV) (Hepatitis delta)." In Genitourinary Infections. Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-017-5080-6_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Smedile, Antonia, and Giorgio Verme. "Hepatitis D Virus." In Viral Hepatitis. Humana Press, 1999. http://dx.doi.org/10.1007/978-1-59259-702-4_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Bowden, Scott. "Hepatitis D Virus." In PCR for Clinical Microbiology. Springer Netherlands, 2010. http://dx.doi.org/10.1007/978-90-481-9039-3_38.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Paraná, Raymundo, Maria Isabel Schinoni, and Mauricio de Souza Campos. "Hepatitis D Virus." In Human Virology in Latin America. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-54567-7_18.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

van Balen, J. A. M., A. A. Demeulemeester, M. Frölich, et al. "Hepatitis D virus." In Memoboek. Bohn Stafleu van Loghum, 2012. http://dx.doi.org/10.1007/978-90-313-9129-5_70.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Rizzetto, Mario. "Hepatitis D Virus." In Clinical Epidemiology of Chronic Liver Diseases. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-94355-8_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Farci, P., and M. Rizzetto. "Hepatitis Delta Virus (HDV): Infection and Disease." In Proceedings in Life Sciences. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-71350-7_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Hepatitis D virus (HDV)"

1

Jachs, M., T. Binter, C. Schmidbauer, et al. "Update on the Austrian epidemiology of Hepatitis D Virus (HDV)." In 54. Jahrestagung & 31. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH (Hybrid Veranstaltung). Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0041-1734294.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Tomaz, Isabella Santos, GIOVANNA MATIAS DUARTE, CECILIA BRUNA DE ALMEIDA, and LETICIA CRISTINA CHAVES BANDEIRA. "IMUNOPROFILAXIA: PREVENÇÃO DAS HEPATITES VIRAIS." In II Congresso Brasileiro de Imunologia On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/ii-conbrai/6034.

Full text
Abstract:
Introdução: As hepatites virais constituem um desafio para a saúde pública no Brasil e no mundo. Essas doenças apresentam dados tão relevantes que a Organização Mundial da Saúde (OMS) assumiu, como um dos seus objetivos, eliminar as hepatites virais até 2030. Com isso, nos últimos 30 anos, diversos avanços científicos contribuíram para o combate dessas doenças, sendo a imunoprofilaxia, por meio das vacinas, uma das principais vertentes desenvolvidas. Objetivos: Realizar uma revisão de literatura sobre a imunoprofilaxia das hepatites virais, evidenciando sua importância para o controle e
APA, Harvard, Vancouver, ISO, and other styles
3

Drechsel, L., M. Pefferkorn, K. Rother, et al. "Das mittlere Hepatitis B Virus (HBV) Oberflächenantigen (MHBs) als neuer Serummarker für das Ansprechen von Heptitis B/Hepatitis D Virus (HDV)-Koinfektionen auf eine Interferon (IFN)-basierte Behandlung." In Viszeralmedizin 2019. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0039-1695322.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Oberhardt, V., H. Karimzadeh, M. Kiraithe, et al. "Viral escape contributes to the failure of hepatitis D virus (HDV)-specific CD8+ T cells and drives population-level evolution of HDV." In 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0038-1677274.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Usman, Z., H. Karimzadeh, U. Protzer, M. Roggendorf, and D. Frishman. "HDVdb: Hepatitis D virus database." In 35. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2019. http://dx.doi.org/10.1055/s-0038-1677295.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Guangyu, Xu, Wei Chengguo, Li Fan, and Xu Guangyu. "Molecular characterization of the hepatitis B virus genotypes A/B/D: A Bayesian methods of evolutionary analysis." In 2011 International Conference on Human Health and Biomedical Engineering (HHBE). IEEE, 2011. http://dx.doi.org/10.1109/hhbe.2011.6029045.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kefalakes, H., X. Horgan, MK Jung, et al. "Liver-resident bystander CD8+ T cells contribute to liver disease pathogenesis in chronic hepatitis D virus infection." In 37. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag KG, 2021. http://dx.doi.org/10.1055/s-0040-1722074.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Görgülü, Esra, Martin Sebastian Schulz, Keerthihan Thiyagarajah, et al. "Hepatitis D Virus Coinfection in Patients with Acute-on-Chronic Liver Failure: Impact on Disease Severity and Survival." In 40. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2024. http://dx.doi.org/10.1055/s-0043-1777647.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Schwarz, M., C. Schwarz, D. Bauer, et al. "Bulevirtid ist sicher und effektiv bei einer Patientin mit Hepatitis D Virus-induzierter Leberzirrhose und Pfortaderthrombose nach einer SARS-CoV-2-Infektion." In 56. Jahrestagung & 33. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie – ÖGGH & ˶Pre˵ Symposium der young ÖGGH. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0043-1769076.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Allweiss, Lena, Annika Volmari, Yvonne Ladiges, et al. "Strong decline of intrahepatic HDV markers and signs of liver inflammation after 48 weeks of treatment with Bulevirtide in chronic hepatitis D patients: Combined intrahepatic results from the clinical trials MYR203 and MYR301." In 39. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber. Georg Thieme Verlag, 2023. http://dx.doi.org/10.1055/s-0042-1760059.

Full text
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!